Genome Organization: Painting chromosomes in the nucleus
The genome of a mammal consists of about two meters of DNA and this DNA must somehow fit inside a nucleus that has a diameter of just ~10 microns (Misteli, 2008). To achieve this feat, the DNA interacts with various proteins to form a very compact and highly ordered complex called chromatin. The genetic material inside the nucleus is also divided into a number of chromosomes.
Recent advances in molecular biology and imaging techniques have begun to shed light on the organization of the DNA, chromatin, and chromosomes within the nucleus. The transcriptional profile of a gene directly influences its position within the nucleus: more active genes are localized near nuclear pores, whereas less active genes are positioned away from these pores (Casolari et al., 2004; Capelson et al., 2010; Pascual-Garcia and Capelson, 2014). It is also known that chromatin is arranged in loops, and that individual chromosomes are separated into non-overlapping regions called chromosome territories (Rao et al., 2014; Wang et al., 2016). However, there are many aspects of the organization of DNA, chromatin, and chromosomes within the nucleus that are not fully understood.
A technique called DNA FISH (short for fluorescence in situ hybridization) has made crucial contributions to our current understanding of chromatin structure, and the introduction of 'oligopaint' technology has made this approach cheaper, faster and more adaptable (Beliveau et al., 2012). Similar to any oligo, an oligopaint is essentially a length of synthetic DNA that has been designed to bind or hybridize to both natural DNA and to other synthetic DNA molecules. Now, in eLife, Scott Kennedy of Harvard Medical School and colleagues – including Brandon Fields (who is also at the University of Wisconsin-Madison) and Son Nguyen as joint first authors, and Guy Nir – report how they have developed a multiplexed version of the oligopaint technology that allows them to simultaneously visualize all six of the chromosomes in the worm Caenorhabditis elegans at virtually any developmental time and in any cell type (Fields et al., 2019).
Fields et al. used a combination of oligopaints, bridging oligos and detection oligos to study genome organization in C. elegans. Each of the 170,594 oligopaints in the library was 150 bases long and contained four 'barcodes' plus a 42-base region that hybridized to a specific region on a specific chromosome in C. elegans (Figure 1). Each bridging oligo contained a region that hybridized to one of the barcodes on the oligopaint, and a region that hybridized to a detection oligo. The detection oligo was fused to a fluorescent dye, which made it possible to see where the oligopaint was, and hence where the specific region of the chromosome was. Fields et al. used three different fluorescent dyes (red, green, and blue) to label the oligopaints in the experiments. Additionally, pairwise combinations of these fluorescent dyes can be employed on a single oligopaint by using two barcodes with two bridging oligos and two detection oligos, which generates a total of six distinct fluorescent patterns.

Using the multiplexed DNA FISH method to visualize chromosomes in C. elegans.
(A) The oligopaints used by Fields et al. contained a chromosome barcode (orange), a 3 Mb barcode (blue), a 500 kb barcode (purple), a 42-base region (grey) that hybridizes to a region of interest on a specific chromosome, and a 3′ barcode (green). The first stage in the process (pale blue boxed region) involves the hybridization of the 42-base region in the oligopaint to its target (1); a bridging oligo then hybridizes to one of the barcodes on the oligopaint (2); a detection oligo with a fluorescent dye then hybridizes to the bridging oligo (3). It is also possible (yellow boxed region) for a second bridging oligo to hybridize to the 3′ barcode on the oligopaint and increase the number of genome regions that can be detected within a single nucleus. (B) This approach can be used to determine the location of different chromosomes within the nucleus by using bridging oligos that bind to the chromosome barcode on the oligopaints specific to each chromosome, along with detection oligos with different fluorescent dyes (top schematic: green for chromosome II; red for chromosome IV). Likewise, the location of different regions within the same chromosome can be determined by using bridging oligos that bind to either the 3 Mb or 500 kb barcodes on the oligopaint specific to one chromosome (bottom schematic). Here blue fluorescence from the 3′ barcode and red fluorescence from the 500 kb barcode combine to give purple fluorescence; blue fluorescence from the 3′ barcode and green fluorescence from the 3 Mb barcode combine to give orange fluorescence. The dotted line represents the region of the nucleus occupied by chromosome IV.
The barcodes make it possible to label (and subsequently visualize) either a whole chromosome, a 3 megabase subregion of a chromosome, or a 500 kilobase subregion (Figure 1). These barcode sequences also enable the re-amplification of the oligopaint library to create an infinitely renewable library. Moreover, the fluorescently pre-labeled detection oligos eliminate the need to directly label each oligopaint, which when combined with the bridging oligos, makes the oligopaint method both very cost effective and versatile. Indeed, Fields et al. were able to visualize all six chromosomes within multiple tissues types in C. elegans including oocytes, germ line cells, intestinal cells, hypodermal cells, and neuronal cells.
Highlighting the power of this method, Fields et al. used the multiplexed DNA FISH method to explore important questions about genome organization. For example, does aging alter the organization of the genome in C. elegans? Remarkably, they observed that the intestinal cells in one-day-old animals displayed distinct chromosome territories that were not present in ten-day-old animals. The disorganization of higher-order chromosome structures has been implicated in aging-related diseases (Evans et al., 2019), but further studies are needed to understand the mechanistic relationship between aging and genome organization. Fields et al. were also able to identify genes that were involved in establishing and/or maintaining chromosome territories (such as the gene that encodes a protein called MES-3).
The ability of multiplexed DNA FISH to visualize chromosomes in intact animals will help the C. elegans community to address fundamental questions about the establishment, maintenance and regulation of higher-order chromatin organization in this important model organism. Further, combining this method with cell lineage maps for C. elegans could make it possible to understand the effect of development and cell differentiation on genome organization. Indeed, oligopaints give the C. elegans community the opportunity to illuminate how the organization and regulation of the genome are shaped by multiple processes and cell types within a developing and aging organism.
References
-
The three-dimensional organization of the genome in cellular senescence and age-associated diseasesSeminars in Cell & Developmental Biology 90:154–160.https://doi.org/10.1016/j.semcdb.2018.07.022
-
Physiological importance of RNA and protein mobility in the cell nucleusHistochemistry and Cell Biology 129:5–11.https://doi.org/10.1007/s00418-007-0355-x
-
Nuclear pores as versatile platforms for gene regulationCurrent Opinion in Genetics & Development 25:110–117.https://doi.org/10.1016/j.gde.2013.12.009
Article and author information
Author details
Publication history
Copyright
© 2019, Cahoon and Libuda
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,402
- views
-
- 234
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
- Chromosomes and Gene Expression
Meiotic crossover recombination is essential for both accurate chromosome segregation and the generation of new haplotypes for natural selection to act upon. This requirement is known as crossover assurance and is one example of crossover control. While the conserved role of the ATPase, PCH-2, during meiotic prophase has been enigmatic, a universal phenotype when pch-2 or its orthologs are mutated is a change in the number and distribution of meiotic crossovers. Here, we show that PCH-2 controls the number and distribution of crossovers by antagonizing their formation. This antagonism produces different effects at different stages of meiotic prophase: early in meiotic prophase, PCH-2 prevents double-strand breaks from becoming crossover-eligible intermediates, limiting crossover formation at sites of initial double-strand break formation and homolog interactions. Later in meiotic prophase, PCH-2 winnows the number of crossover-eligible intermediates, contributing to the designation of crossovers and ultimately, crossover assurance. We also demonstrate that PCH-2 accomplishes this regulation through the meiotic HORMAD, HIM-3. Our data strongly support a model in which PCH-2’s conserved role is to remodel meiotic HORMADs throughout meiotic prophase to destabilize crossover-eligible precursors and coordinate meiotic recombination with synapsis, ensuring the progressive implementation of meiotic recombination and explaining its function in the pachytene checkpoint and crossover control.
-
- Cancer Biology
- Chromosomes and Gene Expression
Despite exciting developments in cancer immunotherapy, its broad application is limited by the paucity of targetable antigens on the tumor cell surface. As an intrinsic cellular pathway, nonsense-mediated decay (NMD) conceals neoantigens through the destruction of the RNA products from genes harboring truncating mutations. We developed and conducted a high-throughput screen, based on the ratiometric analysis of transcripts, to identify critical mediators of NMD in human cells. This screen implicated disruption of kinase SMG1’s phosphorylation of UPF1 as a potential disruptor of NMD. This led us to design a novel SMG1 inhibitor, KVS0001, that elevates the expression of transcripts and proteins resulting from human and murine truncating mutations in vitro and murine cells in vivo. Most importantly, KVS0001 concomitantly increased the presentation of immune-targetable human leukocyte antigens (HLA) class I-associated peptides from NMD-downregulated proteins on the surface of human cancer cells. KVS0001 provides new opportunities for studying NMD and the diseases in which NMD plays a role, including cancer and inherited diseases.